JP1691538S - - Google Patents

Info

Publication number
JP1691538S
JP1691538S JPD2020-27487F JP2020027487F JP1691538S JP 1691538 S JP1691538 S JP 1691538S JP 2020027487 F JP2020027487 F JP 2020027487F JP 1691538 S JP1691538 S JP 1691538S
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JPD2020-27487F
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of JP1691538S publication Critical patent/JP1691538S/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JPD2020-27487F 2020-06-20 2020-12-21 Active JP1691538S (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29738903 2020-06-20

Publications (1)

Publication Number Publication Date
JP1691538S true JP1691538S (enExample) 2021-08-02

Family

ID=77057678

Family Applications (2)

Application Number Title Priority Date Filing Date
JPD2020-27487F Active JP1691538S (enExample) 2020-06-20 2020-12-21
JPD2020-27486F Active JP1691537S (enExample) 2020-06-20 2020-12-21

Family Applications After (1)

Application Number Title Priority Date Filing Date
JPD2020-27486F Active JP1691537S (enExample) 2020-06-20 2020-12-21

Country Status (2)

Country Link
US (2) USD995556S1 (enExample)
JP (2) JP1691538S (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD803238S1 (en) * 2016-06-12 2017-11-21 Apple Inc. Display screen or portion thereof with graphical user interface
USD1016090S1 (en) * 2021-06-05 2024-02-27 Apple Inc. Display or portion thereof with graphical user interface
JP1787151S (ja) * 2022-12-07 2024-12-17 遷移グラフィカルユーザインターフェース
USD1067256S1 (en) * 2022-12-07 2025-03-18 EMOCOG Co., Ltd. Display screen or portion thereof with graphical user interface

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7669134B1 (en) * 2003-05-02 2010-02-23 Apple Inc. Method and apparatus for displaying information during an instant messaging session
USD597101S1 (en) * 2008-01-08 2009-07-28 Apple Inc. Animated image for a portion of a display screen
USD625323S1 (en) * 2008-10-01 2010-10-12 Nintendo Co., Ltd. Display with changeable computer-generated icons
USD686637S1 (en) 2009-03-11 2013-07-23 Apple Inc. Display screen or portion thereof with icon
US9858925B2 (en) * 2009-06-05 2018-01-02 Apple Inc. Using context information to facilitate processing of commands in a virtual assistant
USD680125S1 (en) * 2010-11-16 2013-04-16 Apple Inc. Display screen or portion thereof with graphical user interface
KR101332811B1 (ko) * 2012-02-24 2013-11-27 주식회사 팬택 메시지 숨김 기능을 갖는 단말과 그 메시지 숨김 및 복원 방법
USD729263S1 (en) * 2012-05-02 2015-05-12 Samsung Electronics Co., Ltd. Display screen or portion thereof with transitional graphical user interface
KR101375166B1 (ko) * 2012-05-14 2014-03-20 전남대학교산학협력단 문자화장단말기 및 제어방법
KR102008916B1 (ko) * 2012-09-07 2019-08-08 삼성전자주식회사 미확인 콘텐츠 표시 방법 및 그 전자 장치
USD742894S1 (en) 2013-06-10 2015-11-10 Apple Inc. Display screen or portion thereof with graphical user interface
USD757058S1 (en) * 2013-08-02 2016-05-24 Guangzhou Ucweb Computer Technology Co., Ltd. Display with animated graphical user interface
USD751117S1 (en) 2014-02-07 2016-03-08 Apple Inc. Display screen or portion thereof with animated graphical user interface
USD710879S1 (en) * 2014-04-14 2014-08-12 Interactive Memories, Inc. Display screen having a graphical user interface
USD758386S1 (en) * 2014-04-29 2016-06-07 Tencent Technology (Shenzhen) Company Limited Portion of a display screen with an animated graphical user interface
US10691473B2 (en) * 2015-11-06 2020-06-23 Apple Inc. Intelligent automated assistant in a messaging environment
US20170200128A1 (en) * 2016-01-07 2017-07-13 Facebook, Inc. Creating digital events utilizing natural language processing
USD821409S1 (en) * 2016-05-16 2018-06-26 Google Llc Display screen or portion thereof with a graphical user interface for messaging
US11112963B2 (en) * 2016-05-18 2021-09-07 Apple Inc. Devices, methods, and graphical user interfaces for messaging
USD803238S1 (en) * 2016-06-12 2017-11-21 Apple Inc. Display screen or portion thereof with graphical user interface
USD825612S1 (en) 2016-07-27 2018-08-14 Apple Inc. Display screen or portion thereof with graphical user interface
US20180234367A1 (en) * 2017-02-13 2018-08-16 Marketing Architects, Inc. User transition from messaging interface to web-based interface
USD882602S1 (en) * 2017-07-28 2020-04-28 Verisign, Inc. Display screen or portion thereof with a sequential graphical user interface of a mobile device
USD875130S1 (en) 2017-11-20 2020-02-11 Line Corporation Portable device display screen with animated graphical user interface
USD845337S1 (en) * 2017-12-01 2019-04-09 Nasdaq, Inc. Display screen or portion thereof with animated graphical user interface
USD879822S1 (en) * 2018-08-13 2020-03-31 Facebook, Inc. Display screen with animated graphical user interface

Also Published As

Publication number Publication date
USD1080656S1 (en) 2025-06-24
USD995556S1 (en) 2023-08-15
JP1691537S (enExample) 2021-08-02

Similar Documents

Publication Publication Date Title
BR102021007058A2 (enExample)
BR102020022030A2 (enExample)
AR134288A1 (es) UN PÉPTIDO CÍCLICO PARA ATRAPAR LA INTERLEUCINA-1b
AR134271A1 (es) Variantes de cnp, conjugados y formulaciones de los mismos
AR134276A1 (es) ANTICUERPOS ANTI-MIGIS-a Y MÉTODOS DE USO DE ESTOS
AR134275A1 (es) Anticuerpos cd24
AR134264A1 (es) Correctores farmacológicos de rodopsina y sus usos
AR134266A1 (es) Métodos para tratar el cáncer utilizando compuestos que inhiben la pkmyt1
AR134263A1 (es) Tratamiento de covid persistente con composición de vesículas extracelulares
AR134262A1 (es) Formulación líquida de agente biológico en almacenamiento estable
AR134259A1 (es) Compuestos de pirimidina bicíclicos, métodos y usos de estos
AR134258A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134257A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134219A1 (es) Derivados de (piperidin-4-il)-1,5-naftiridina y (piperidin-4-il)quinolina sustituidos y usos de los mismos
AR134215A1 (es) Compuestos de tiazol y métodos de uso
AR134214A1 (es) Redireccionamiento de cápsides de aav para dirigirlas al sistema nervioso central
AR134200A1 (es) Combinaciones de herbicida / protector a base de herbicidas de la clase de las amidas de ácido n-(1,3,4-oxadiazol-2-il)fenilcarboxílico quirales y sus sales
AR134206A1 (es) Degradantes y usos de los mismos
AR134198A1 (es) Compuestos de proteasa 1 de procesamiento específico de ubiquitina (usp1)
AR134193A1 (es) Métodos para tratar tumores tenosinoviales de células gigantes
AR134194A1 (es) Nuevos moduladores de nitrato, amonio y potasio en plantas y métodos para usarlos
AR134185A1 (es) Anticuerpos anti-receptor de transferrina y usos de estos
AR134180A1 (es) Péptidos inmunogénicos de magea1, proteínas de unión que reconocen los péptidos inmunogénicos de magea1 y usos de los mismos
AR134176A1 (es) VARIANTES DEL DOMINIO Fc CON UNIÓN MEJORADA AL RECEPTOR Fc
AR134164A1 (es) Modificadores covalentes reversibles de lisina de cdk2 y usos de los mismos